Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „infliximab“
Suchtreffer
Begriffe & Kennungen
Remsima · 4.8 · Immunogenicity Antibodies to infliximab were detected in 4 (7.7%) patients through week 54.
Eintrag öffnenRemsima · 4.8 · In Crohn's disease and ulcerative colitis patients on maintenance treatment, the incidence of anti-infliximab
Eintrag öffnenRemsima · 4.8 · In a Phase II study aimed at evaluating infliximab in CHF, higher incidence of mortality due to worsening of h
Eintrag öffnenRemsima · 4.8 · In a Phase II study aimed at evaluating infliximab in CHF, higher incidence of mortality due to worsening of h
Eintrag öffnenRemsima · 4.8 · In a Phase II study aimed at evaluating infliximab in CHF, higher incidence of mortality due to worsening of h
Eintrag öffnenRemsima · 4.8 · In clinical studies 36% of infliximab-treated patients were treated for infections compared with 25% of placeb
Eintrag öffnenRemsima · 4.8 · In clinical studies 36% of infliximab-treated patients were treated for infections compared with 25% of placeb
Eintrag öffnenRemsima · 4.8 · In clinical studies delayed hypersensitivity reactions have been uncommon and have occurred after infliximab-f
Eintrag öffnenRemsima · 4.8 · In clinical studies delayed hypersensitivity reactions have been uncommon and have occurred after infliximab-f
Eintrag öffnenRemsima · 4.8 · In clinical studies delayed hypersensitivity reactions have been uncommon and have occurred after infliximab-f
Eintrag öffnenRemsima · 4.8 · In clinical studies with infliximab in which 5,780 patients were treated, representing 5,494 patient years, 5
Eintrag öffnenRemsima · 4.8 · In clinical studies with infliximab in which 5,780 patients were treated, representing 5,494 patient years, 5
Eintrag öffnenRemsima · 4.8 · In clinical studies with infliximab in which 5,780 patients were treated, representing 5,494 patient years, 5
Eintrag öffnenRemsima · 4.8 · In long-term safety follow-up of clinical studies with infliximab of up to 5 years, representing 6,234 patient
Eintrag öffnenRemsima · 4.8 · In long-term safety follow-up of clinical studies with infliximab of up to 5 years, representing 6,234 patient
Eintrag öffnenRemsima · 4.8 · In long-term safety follow-up of clinical studies with infliximab of up to 5 years, representing 6,234 patient
Eintrag öffnenRemsima · 4.8 · In rheumatoid arthritis clinical studies, the incidence of serious infections was greater in infliximab plus m
Eintrag öffnenRemsima · 4.8 · In rheumatoid arthritis clinical studies, the incidence of serious infections was greater in infliximab plus m
Eintrag öffnenRemsima · 4.8 · In rheumatoid arthritis clinical studies, the incidence of serious infections was greater in infliximab plus m
Eintrag öffnenRemsima · 4.8 · In rheumatoid arthritis patients on maintenance treatment, the incidence of anti-infliximab antibodies followi
Eintrag öffnen